Further support for a role of synaptic proteins in autism spectrum disorders

A new study combines genetic and neurobiological approaches to confirm that synaptic mutations increase the risk of autism spectrum disorders (ASDs). It also highlights a role for modifier genes in these disorders. Published in PLoS Genetics, this research was conducted by researchers at the Institut Pasteur, the Paris Diderot University, the Robert Debré Hospital, the Gillberg Neuropsychiatry centre, Ulm University and the Centre National de Genotypage, in collaboration with other institutions in Europe.

ASDs are a heterogeneous group of neurodevelopmental disorders with a complex inheritance pattern characterized by impairments in social interaction and communication, and by restricted and repetitive behavior. ASDs appear before the age of three years and affect 1/100 children, with a higher risk for males than for females. Several genes involved in ASD have been identified in patients with ASD, but only recently have we started to learn about their effects on neuronal functions and their interaction with other genetic variations.

In their new study, Leblond and collaborators identified altering SHANK2, a gene that encodes a scaffolding protein located at synapses (contacts between neuronal cells). The researchers showed that several of the mutations observed in patients reduced the number of synapses in neuronal cell cultures. Further genomic analysis of three patients carrying SHANK2 deletions identified additional rare genomic imbalances, previously associated with other neuropsychiatric disorders, that could act as modifier genes by modulating the disorder.

These results emphasise the importance of synaptic gene dysfunction in ASD and also highlight a role for modifier genes, confirming a "multiple hit model" for ASD. "A better knowledge of these genetic interactions will be necessary to understand the complex inheritance pattern of ASD", concludes Thomas Bourgeron, an author on the paper.

More information: Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, et al. (2012) Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders. PLoS Genet 8(2): e1002521. doi:10.1371/journal.pgen.1002521

Related Stories

More gene mutations linked to autism risk

Jun 25, 2009

(PhysOrg.com) -- More pieces in the complex autism inheritance puzzle are emerging in the latest study from a research team including geneticists from The Children's Hospital of Philadelphia, the University ...

Autism susceptibility genes identified

Mar 25, 2010

Two genes have been associated with autistic spectrum disorders (ASD) in a new study of 661 families. Researchers writing in BioMed Central's journal Molecular Autism found that variations in the genes for two brain protei ...

Recommended for you

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.